 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vaxil Bio Ltd. is an immunotherapy biotech company, which is engaged in the development of immunotherapies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. The firm's pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada.

Current Price	$0.0147
Prev Close	$0.0148
Open	$0.0147
Dividend Yield	0.00%
50-Day Moving Average	$0.0136
Beta	0.46
Avg. Volume	5,408.47
PE Ratio	-4.48

52-Week High	$0.034
52-Week Low	$0.0042
Market Capitalization	$2.03M
EPS	-$0.0033
Price to Book	2.42
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-2.03

VXLLF Vaxil Bio Ltd

About

Feed

Fundamentals

News